Literature DB >> 31560956

The Lord of the Lungs: The essential role of pulmonary surfactant upon inhalation of nanoparticles.

Cristina Garcia-Mouton1, Alberto Hidalgo1, Antonio Cruz1, Jesús Pérez-Gil2.   

Abstract

The rapid development of nanotechnology is opening a huge world of promising possibilities in healthcare, but this is also increasing the necessity to study the potential risk of nanoparticles on public health and the environment. Since the main route for airborne particles to enter into our organism is through the lungs, it has become essential to prove that the nanoparticles generated by human activities do not compromise the respiratory function. This review explains the key role of pulmonary surfactant to sustain the normal function of breathing, as well as the stability and immunity of lungs. Particular emphasis is made on the importance of analysing the features of nanoparticles, defining their interactions with surfactant and unravelling the mutual effects. The implication of the nanoparticle-surfactant interaction on the function and fate of both structures is described, as well as the main in vitro methodologies used to evaluate this interaction. Finally, the incorporation of pulmonary surfactant in appropriate in vitro models is used in order to obtain an extensive understanding of how nanoparticles may act in the context of the lung. The main goal of this review is to offer a general view on inhaled nanoparticles and their effects on the structure and function of lungs derived from their interaction with the pulmonary surfactant system.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Airborne particles; Drug delivery; In vitro air-blood barrier; Inhalation; Lung

Mesh:

Substances:

Year:  2019        PMID: 31560956     DOI: 10.1016/j.ejpb.2019.09.020

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  19 in total

1.  Atomic Force Microscopy Imaging of Adsorbed Pulmonary Surfactant Films.

Authors:  Lu Xu; Yi Yang; Yi Y Zuo
Journal:  Biophys J       Date:  2020-07-14       Impact factor: 4.033

2.  Lung surfactant negatively affects the photodynamic inactivation of bacteria-in vitro and molecular dynamic simulation analyses.

Authors:  Giulia Kassab; Johan Sebastian Diaz Tovar; Lucas Miguel Pereira Souza; Rayla Kelly Magalhães Costa; Rudielson Santos Silva; André Silva Pimentel; Cristina Kurachi; Vanderlei Salvador Bagnato
Journal:  Proc Natl Acad Sci U S A       Date:  2022-06-13       Impact factor: 12.779

Review 3.  A toxicological profile of silica nanoparticles.

Authors:  James Y Liu; Christie M Sayes
Journal:  Toxicol Res (Camb)       Date:  2022-07-16       Impact factor: 2.680

Review 4.  Lung Models to Evaluate Silver Nanoparticles' Toxicity and Their Impact on Human Health.

Authors:  Jesús Gabriel González-Vega; Juan Carlos García-Ramos; Rocio Alejandra Chavez-Santoscoy; Javier Emmanuel Castillo-Quiñones; María Evarista Arellano-Garcia; Yanis Toledano-Magaña
Journal:  Nanomaterials (Basel)       Date:  2022-07-05       Impact factor: 5.719

5.  Molecular basis of transport of surface functionalised gold nanoparticles to pulmonary surfactant.

Authors:  Fengxuan Jiao; Sheikh I Hossain; Jianbing Sang; Suvash C Saha; YuanTong Gu; Zak E Hughes; Neha S Gandhi
Journal:  RSC Adv       Date:  2022-06-17       Impact factor: 4.036

6.  Shape matters-the interaction of gold nanoparticles with model lung surfactant monolayers.

Authors:  Sheikh I Hossain; Zhen Luo; Evelyne Deplazes; Suvash C Saha
Journal:  J R Soc Interface       Date:  2021-10-13       Impact factor: 4.293

7.  Disease Models: Lung Models for Testing Drugs Against Inflammation and Infection.

Authors:  Patrick Carius; Justus C Horstmann; Cristiane de Souza Carvalho-Wodarz; Claus-Michael Lehr
Journal:  Handb Exp Pharmacol       Date:  2021

Review 8.  Nanoparticle Delivery Systems with Cell-Specific Targeting for Pulmonary Diseases.

Authors:  Zicheng Deng; Gregory T Kalin; Donglu Shi; Vladimir V Kalinichenko
Journal:  Am J Respir Cell Mol Biol       Date:  2021-03       Impact factor: 6.914

9.  Polyhydroxyalkanoate Nanoparticles for Pulmonary Drug Delivery: Interaction with Lung Surfactant.

Authors:  Olga Cañadas; Andrea García-García; M Auxiliadora Prieto; Jesús Pérez-Gil
Journal:  Nanomaterials (Basel)       Date:  2021-06-03       Impact factor: 5.076

Review 10.  Interactions of particulate matter and pulmonary surfactant: Implications for human health.

Authors:  Feifei Wang; Jifang Liu; Hongbo Zeng
Journal:  Adv Colloid Interface Sci       Date:  2020-08-19       Impact factor: 12.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.